Recently, it has been suggested that abnormalities in bone‐mineral axis and deficiency of erythropoietin (EPO) or klotho may directly aggravate cardiac hypertrophy and participate in the pathogenesis of worsening of renal function and cardiovascular complication 6, 7. This evidence concerns the gene EPO and cardiac hypertrophy.